Butensky & Cohen Financial Security Inc. boosted its holdings in shares of CVS Health Corp (NYSE:CVS) by 12.3% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 24,022 shares of the pharmacy operator’s stock after buying an additional 2,630 shares during the period. CVS Health makes up about 1.7% of Butensky & Cohen Financial Security Inc.’s holdings, making the stock its 21st biggest position. Butensky & Cohen Financial Security Inc.’s holdings in CVS Health were worth $1,953,000 at the end of the most recent quarter.
Other hedge funds have also recently modified their holdings of the company. Pathstone Family Office LLC raised its holdings in CVS Health by 341.0% in the 2nd quarter. Pathstone Family Office LLC now owns 1,270 shares of the pharmacy operator’s stock valued at $2,353,000 after acquiring an additional 982 shares in the last quarter. Fieldpoint Private Securities LLC raised its holdings in shares of CVS Health by 333.3% in the 2nd quarter. Fieldpoint Private Securities LLC now owns 1,300 shares of the pharmacy operator’s stock worth $105,000 after buying an additional 1,000 shares in the last quarter. Arcadia Investment Management Corp MI raised its holdings in shares of CVS Health by 119.6% in the 3rd quarter. Arcadia Investment Management Corp MI now owns 1,333 shares of the pharmacy operator’s stock worth $108,000 after buying an additional 726 shares in the last quarter. MPS Loria Financial Planners LLC acquired a new position in shares of CVS Health in the 2nd quarter worth approximately $119,000. Finally, Gemmer Asset Management LLC increased its holdings in CVS Health by 15.3% during the 2nd quarter. Gemmer Asset Management LLC now owns 1,509 shares of the pharmacy operator’s stock valued at $121,000 after purchasing an additional 200 shares in the last quarter. 81.62% of the stock is currently owned by institutional investors.
In other CVS Health news, EVP Lisa Bisaccia sold 29,445 shares of the business’s stock in a transaction that occurred on Thursday, December 21st. The shares were sold at an average price of $75.00, for a total transaction of $2,208,375.00. Following the completion of the transaction, the executive vice president now directly owns 15,556 shares in the company, valued at $1,166,700. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.61% of the stock is owned by insiders.
CVS has been the subject of a number of recent analyst reports. Jefferies Group raised their price target on CVS Health from $82.00 to $86.00 and gave the company a “hold” rating in a report on Friday, September 15th. Royal Bank of Canada assumed coverage on CVS Health in a research report on Tuesday, September 19th. They issued an “outperform” rating and a $95.00 price target on the stock. Oppenheimer restated a “buy” rating and issued a $95.00 price target on shares of CVS Health in a research report on Monday, October 9th. Needham & Company LLC reiterated a “hold” rating on shares of CVS Health in a report on Thursday, October 12th. Finally, SunTrust Banks set a $85.00 target price on CVS Health and gave the stock a “buy” rating in a report on Thursday, October 12th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the company. CVS Health has an average rating of “Buy” and an average price target of $86.66.
Shares of CVS Health Corp (CVS) traded up $1.58 during trading hours on Thursday, hitting $79.02. The stock had a trading volume of 7,158,159 shares, compared to its average volume of 10,810,000. CVS Health Corp has a 12 month low of $66.45 and a 12 month high of $84.72. The company has a market capitalization of $80,050.00, a PE ratio of 16.33, a PEG ratio of 1.38 and a beta of 0.90. The company has a current ratio of 1.05, a quick ratio of 0.55 and a debt-to-equity ratio of 0.67.
CVS Health (NYSE:CVS) last issued its quarterly earnings data on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.49 by $0.01. The company had revenue of $46.18 billion during the quarter, compared to analysts’ expectations of $46.17 billion. CVS Health had a return on equity of 16.96% and a net margin of 2.77%. The business’s revenue was up 3.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.64 earnings per share. analysts forecast that CVS Health Corp will post 5.9 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 2nd. Shareholders of record on Wednesday, January 24th will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 23rd. This represents a $2.00 annualized dividend and a yield of 2.53%. CVS Health’s dividend payout ratio is currently 41.32%.
WARNING: “Butensky & Cohen Financial Security Inc. Has $1.95 Million Position in CVS Health Corp (CVS)” was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this article on another domain, it was illegally copied and republished in violation of international trademark & copyright law. The legal version of this article can be accessed at https://www.dispatchtribunal.com/2018/01/11/butensky-cohen-financial-security-inc-acquires-2630-shares-of-cvs-health-corp-cvs.html.
CVS Health Profile
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.